Last reviewed · How we verify

NCT04768621: MediTAAF

Health Consequences of Wintering in the French Southern and Antarctic Territories

Completed NA Last updated 21 September 2023
What this trial tests

NA trial testing Questionary in Environmental Exposure in 232 participants. Completed in 19 June 2021.

Timeline
20 April 2021
Primary endpoint
19 June 2021
19 June 2021

Quick facts

Lead sponsorCentre Hospitalier Universitaire de la Réunion
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment232
Start date20 April 2021
Primary completion19 June 2021
Estimated completion19 June 2021
Sites1 location across Reunion

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de la Réunion

Who can join

Adults 18 to 99, any sex, with Environmental Exposure or Winter Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Polar stays expose people to extreme climate, isolation and confinement. The combination of these factors induces psychological disorders, sleep disorders, immune and endocrine disturbances, and deficiencies. In the TAAF, (French Southern and Antarctic Lands) two types of population coexist: winter residents, exposed to these stressors over long periods, and country people, who benefit from milder conditions and only make short stays. In this context, the investigators have decided to set up this cohort study with the objective of comparing the state of health of the winterers of the TAAF from 2012 to 2017 with that of the country people of the same period, before their stay, during and the year following their return.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionary

Trials testing the same drug.

Other recruiting trials for Environmental Exposure

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de la Réunion trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04768621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing